Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The benefits of blood pressure lowering treatment for prevention of cardiovascular disease are well established. However, the extent to which these effects differ by baseline blood pressure, presence of comorbidities, or drug class is less clear. We therefore performed a systematic review and meta-analysis to clarify these differences.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Lancet

Title: Lancet (London, England)

ISSN (Electronic): 1474-547X

ISSN (Print): 0140-6736

Publication date (Electronic): Mar 5 2016

Volume: 387

Issue: 10022

Affiliations

[1 ] The George Institute for Global Health, University of Oxford, Oxford, UK.

[2 ] The George Institute for Global Health, University of Oxford, Oxford, UK; Institute of Cardiovascular Sciences, University of Manchester, Manchester, UK.

[3 ] The George Institute for Global Health, University of Oxford, Oxford, UK; King's College Hospital NHS Foundation Trust, London, UK.

[4 ] Clinical Trial Service Unit and Epidemiological Studies Unit, University of Oxford, Oxford, UK.

[5 ] The George Institute for Global Health, University of Sydney, Sydney, NSW, Australia.

[6 ] The George Institute for Global Health, University of Oxford, Oxford, UK. Electronic address: kazem.rahimi@georgeinstitute.ox.ac.uk.

Article

Publisher Item ID: S0140-6736(15)01225-8

DOI: 10.1016/S0140-6736(15)01225-8

PubMed ID: 26724178

SO-VID: a26c9f81-6bed-41c8-8bdc-3ad1a088b0cb

History

Data availability:

Comments

Comment on this article

scite_

Cited by 1,126

See all cited by

- Version 1